Primary Cutaneous Non-Hodgkin Lymphoma — Trials

Primary Cutaneous Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

352 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 67
Recruiting: 32
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: Mayo Clinic
Termination share: 38.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (77)

clinicaltrialsPublishedShowing 1–14 of 14 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07055477	A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)	recruiting	Phase 1	60	National Cancer Institute (NCI)NIH	1	Aug 24, 2026	clinicaltrials
NCT07754890	Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma	recruiting	Phase 1 / Phase 2	65	Peking Union Medical College HospitalOTHER	1	Aug 12, 2026